24 studies found for: Open Studies | "Tongue Neoplasms"
|21||Not yet recruiting||
PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed By Surgery
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
† Indicates status has not been verified in more than two years